| Previous Section | Index | Home Page |
24 Mar 2004 : Column 931W—continued
Radiographer Vacancies
Simon Hughes: To ask the Secretary of State for Health how many vacancies there are for radiographers in the NHS in (a) Greater London and (b) each London borough. [162365]
Mr. Hutton: Information on qualified diagnostic and qualified therapeutic radiography staff vacancies in national health service trusts by strategic health authority and primary care trust in London has been placed in the Library.
Seroxat
Tim Loughton: To ask the Secretary of State for Health how many children in England are being prescribed Seroxat in (a) under 20 mg doses, (b) 20 mg doses and (c) over 20 mg doses. [162559]
Dr. Ladyman: Information is not available on the number of children who are prescribed Paroxetine Hydrochloride (Seroxat).
However, estimates of the number of prescription items of Paroxetine Hydrochloride that were dispensed in the community in England to children are available. These estimates show that in 2002 (the latest year for
24 Mar 2004 : Column 932W
which figures are available) around 43,000 prescription items of Paroxetine Hydrochloride were dispensed in the community to children. This accounts for about one per cent. of all prescription items of Paroxetine Hydrochloride that were dispensed in the community.
The estimate is derived from the Prescription Cost Analysis (PCA) system which covers all prescription items dispensed in the community in England. It does not include items dispensed in hospitals/clinics or private prescriptions. The estimate includes totals of prescription items for the chemical entity Paroxetine rather than Seroxat on its own, thus ensuring that any items dispensed generically are also included in the figures.
As with all prescription items, information on the dosage is not available.
Tim Loughton: To ask the Secretary of State for Health how many people are prescribed Seroxat in England; and what the number was in each of the last five years. [162562]
Ms Rosie Winterton: Information is not available in the requested format. The number of prescription items of paroxetine (seroxat) dispensed in the community in England in each of the last five years is shown in the table.
| Year | Number of prescription items (millions) |
|---|---|
| 1998 | 2.7 |
| 1999 | 3.1 |
| 2000 | 3.5 |
| 2001 | 3.8 |
| 2002 | 3.7 |
| 2003(22) | 2.2 |
Notes:
The data is from the Prescription Cost Analysis (PCA) system which covers ail prescription items dispensed in the community in England. It does not include items dispensed in hospitals/clinics or private prescriptions.
Paroxetine (Seroxat) is a selective-serotonin reuptake inhibitor and is defined in the British National Formulary (BNF) paragraph 4.3.3.
This data includes all items for the chemical entity Paroxetine; this includes the brand Seroxat and any generic prescriptions.
Data for 2003 is January to September only.
Tim Loughton: To ask the Secretary of State for Health what percentage of general practitioners prescribe Seroxat in doses larger than 20 mg. [162563]
Ms Rosie Winterton: Information is not available in the requested format.
In 2002, 80 per cent. of all paroxetine (Seroxat) prescription items that were dispensed in the community in England were for the 20 mg tablet and 18 per cent. were for the 30 mg tablet. However, it is not possible to link this data back to individuals or general practitioners, so we do not know what doses individuals have been prescribed. Therefore, it is not possible to infer the percentage of practitioners prescribing paroxetine in doses larger than 20 mg from this information.
24 Mar 2004 : Column 933W
Speech and Language Therapists
Anne Picking: To ask the Secretary of State for Health (1) what the average time is that a person has had to wait to be registered as a speech and language therapist in the last five years; [160250]
- (2) how many applications to register speech and language therapists are waiting to be processed by the Health Professions Council; [160251]
(3) what plans he has to speed up the process of registering speech and language therapists. [160252]
Mr. Hutton: The Health Professions Council is an independent statutory regulatory body and this information is available directly from that organisation.
Risperidone
Mr. Burstow: To ask the Secretary of State for Health what representations he has received from Johnson and Johnson on the risk of stroke in atypical antipsychotics used on patients with dementia. [162424]
Dr. Ladyman: The marketing authorisation holder for risperidone, Janssen Cilag UK Ltd., is a wholly owned subsidiary of the United States company Johnson and Johnson. Aside from the data and interpretation received from Janssen Cilag and their corresponding applications to vary the UK Marketing Authorisations in respect of the risk of stroke associated with use of risperidone in patients with dementia, no representations have been received from the company.
Student Midwives
Ross Cranston: To ask the Secretary of State for Health what (a) the total cost and (b) the cost per individual to his Department was of the training of student midwives in each year since 1997. [161545]
Mr. Hutton: The total cost and cost per individual of training student midwives for each year since 1997 are shown in the table.
| Total cost(£ million) | Cost per individual (£) bursary, salary and tuition | |
|---|---|---|
| 1997–98 | 42.6 | 11,988 |
| 1998–99 | 34.6 | 10,573 |
| 1999–2000 | 45.6 | 13,169 |
| 2000–01 | 51.4 | 13,959 |
| 2001–02 | 58.7 | 14,461 |
| 2002–03 | 59.0 | 14,132 |
| 2003–04 | 63.3 | 13,323 |
Notes:
1. 1997–98 and 2003–04 are forecasts (actual outturn was only collected from 1999 onwards).
2. Data in the above time series are not strictly comparable due to changes in the way data were collected,
3. Average bursary costs for nurses and midwives added to tuition costs from 2000–01 onwards.
Staffing (London)
Simon Hughes: To ask the Secretary of State for Health how many (a) nurses, (b) midwives, (c) nursing assistants and (d) professionals ancillary to medicine were employed in the area of each primary care trust in
24 Mar 2004 : Column 934W
(i) Greater London and (ii) each London borough in (A) 1997 and (B) the most recent year for which figures are available. [162348]
Mr. Hutton: The information available has been placed in the Library.
Substance Misuse
Mr. Keith Bradley: To ask the Secretary of State for Health what the total NHS budget allocated to substance misuse treatment programmes for (a) drugs and (b) alcohol is in 2003–04. [162615]
Miss Melanie Johnson [holding answer 22 March 2004]: The pooled drug treatment budget totalled £243.6 million in 2003–04, which allowed for an average increase of 24 per cent., to primary care trusts in their allocation from this budget. It is also estimated that £200 million of mainstream national health service expenditure will be spent on drug treatment in 2003–04.
All funding for alcohol treatment services is drawn from the mainstream budgets of the NHS and local authorities. The amounts spent on treatment services from these budgets was substantial, although the method of funding means that it is not possible to give figures on expenditure.
Training Costs
Harry Cohen: To ask the Secretary of State for Health what information he collects on the percentage of annual staffing costs spent on training in the NHS. [162087]
Mr. Hutton: In 2002–03, the latest year for which actual outturn figures are available, the Multi Professional Education and Training (MPET) budget accounted for 11 per cent. of the national health service annual staffing costs. The MPET training budget excludes funds spent by NHS trusts and primary care trusts on training existing staff from within their own budgets because this information is not held centrally.
Tuberculosis
Dr. Murrison: To ask the Secretary of State for Health how many new cases of TB were recorded in each year since 2000. [161168]
Miss Melanie Johnson: The total number of tuberculosis cases reported in England and Wales since 2000 is shown in the table.
| Year | Number of cases |
|---|---|
| 2000 | 6,271 |
| 2001 | 6,597 |
| 2002 | 6,907 |
Note:
(22) Provisional figure.
Source:
Health Protection Agency.
Waiting Lists/Times
Simon Hughes: To ask the Secretary of State for Health how many patients are awaiting (a) in-patient
24 Mar 2004 : Column 935W
admission and (b) initial out-patient assessment in Greater London; and what the figures were in each of the last five years. [162385]
Mr. Hutton [holding answer 18 March 2004]: The latest available figures for in-patient elective admissions for London are shown in the following tables. Information is only collected for first outpatient attendances for those patients waiting over 13 weeks.
Note:
These figures are for London Regional Office.
Source:
Department of Health form KH07
24 Mar 2004 : Column 936W
| SHA Code | 2002–03 Q1 | 2002–03 Q2 | 2002–03 Q3 | 2002–03 Q4 | 2003–04 Q1 | 2003–04 Q2 | 2003–04 Q3 |
|---|---|---|---|---|---|---|---|
| North West London | 31,252 | 32,355 | 32,940 | 30,509 | 30,851 | 28,977 | 29,469 |
| North Central London | 35,696 | 35,767 | 35,600 | 32,480 | 32,670 | 32,040 | 32,742 |
| North East London | 35,559 | 34,994 | 34,290 | 31,482 | 31,031 | 29,615 | 28,716 |
| South East London | 34,711 | 34,261 | 34,160 | 33,002 | 33,034 | 30,576 | 29,297 |
| South East London | 26,917 | 26,191 | 26,608 | 25,762 | 24,508 | 23,386 | 23,194 |
Source:
Department of Health form KH07
Simon Hughes: To ask the Secretary of State for Health how many patients in (a) Greater London and (b) each London borough were awaiting physiotherapy assessment in each six-month interval in the last five years. [162386]
Mr. Hutton [holding answer 18 March 2004]: The information requested is not held centrally.
| Next Section | Index | Home Page |